Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recurrent mantle cell lymphoma after allogeneic bone marrow transplantation presenting as isolated rectal mass.

× No keyword cloud information.

14 in total

1. European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma.

Authors: J M Foran; A Z Rohatiner; D Cunningham; R A Popescu; P Solal-Celigny; M Ghielmini; B Coiffier; P W Johnson; C Gisselbrecht; F Reyes; J A Radford; E M Bessell; B Souleau; A Benzohra; T A Lister
Journal: J Clin Oncol Date: 2000-01 Impact factor: 44.544

2. The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK).

Authors: M Ghielmini; S F Schmitz; K Bürki; G Pichert; D C Betticher; R Stupp; M Wernli; A Lohri; D Schmitter; F Bertoni; T Cerny
Journal: Ann Oncol Date: 2000 Impact factor: 32.976

3. Treatment of mantle-cell lymphoma with Rituximab (chimeric monoclonal anti-CD20 antibody): analysis of factors associated with response.

Authors: J M Foran; D Cunningham; B Coiffier; P Solal-Celigny; F Reyes; M Ghielmini; P W Johnson; C Gisselbrecht; M Bradburn; J Matthews; T A Lister
Journal: Ann Oncol Date: 2000 Impact factor: 32.976

4. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project.

Authors:
Journal: Blood Date: 1997-06-01 Impact factor: 22.113

Review 5. Biology and management of mantle cell lymphoma.

Authors: J P Leonard; E J Schattner; M Coleman
Journal: Curr Opin Oncol Date: 2001-09 Impact factor: 3.645

6. Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: anthracycline does not improve the prognosis.

Authors: P Meusers; M Engelhard; H Bartels; T Binder; H H Fülle; K Görg; U Gunzer; K Havemann; W Kayser; E König
Journal: Hematol Oncol Date: 1989 Sep-Oct Impact factor: 5.271

7. Efficacy of autologous stem cell transplantation in mantle cell lymphoma: a 3-year follow-up study.

Authors: D Decaudin; N Brousse; P Brice; C Haioun; J H Bourhis; P Morel; A Van Hoof; B Souleau; B Quesnel; C Gisselbrecht
Journal: Bone Marrow Transplant Date: 2000-02 Impact factor: 5.483

8. Multiple lymphomatous polyposis of the gastrointestinal tract: prospective clinicopathologic study of 31 cases. Groupe D'étude des Lymphomes Digestifs.

Authors: A Ruskoné-Fourmestraux; A Delmer; A Lavergne; T Molina; N Brousse; J Audouin; J C Rambaud
Journal: Gastroenterology Date: 1997-01 Impact factor: 22.682

Review 9. Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group.

Authors: D D Weisenburger; J M Vose; T C Greiner; J C Lynch; W C Chan; P J Bierman; B J Dave; W G Sanger; J O Armitage
Journal: Am J Hematol Date: 2000-07 Impact factor: 10.047

10. Patients with mantle-cell lymphoma relapsing after autologous stem cell transplantation may be rescued by allogeneic transplantation.

Authors: C Martínez; E Carreras; M Rovira; A Urbano-Ispizua; J Esteve; M Perales; F Fernández; E Montserrat
Journal: Bone Marrow Transplant Date: 2000-09 Impact factor: 5.483